NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value
13. Februar 2024 09:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a commercial stage medical device company focused on reducing the impact of neurological disorders and pain...
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024
08. Januar 2024 09:43 ET
|
NeuroMetrix, Inc.
NeuroMetrix announced today that the Company’s Chairman and CEO, Dr. Shai N. Gozani will present at the Emerging Growth Conference on January 10, 2024.
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)
12. Dezember 2023 09:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix reported the recent presentation of data from a clinical trial of Quell wearable neuromodulation technology in patients with Long COVID.
NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)
05. Dezember 2023 09:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix noted publication of results from a NIH-funded clinical trial of Quell. The paper has been electronically published in The Journal of Pain.
NeuroMetrix Announces One-for-Eight Reverse Stock Split
20. November 2023 09:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effective at 5:00...
NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023
30. Oktober 2023 09:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it will present at the Emerging Growth Conference on Wednesday November 1, 2023 at 3:40PM EDT.
NeuroMetrix Reports Q3 2023 Business Highlights
26. Oktober 2023 07:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and nine month period ended September 30, 2023.
NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call
23. Oktober 2023 11:13 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it plans to issue its Q3 2023 business and financial highlights on October 26, 2023 at 8:00 a.m., Eastern Time.
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia
02. Oktober 2023 09:00 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced that it has been selected as a Proud Sponsor of the National Fibromyalgia Association (NFA).
NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023
28. September 2023 12:19 ET
|
NeuroMetrix, Inc.
NeuroMetrix, Inc. announced today that it will present at the Emerging Growth Conference on October 4, 2023 at 3:55pm EDT.